Hi all,
My positivity around shorter term recovery is returning and with it just a "heads up" note.
1. ACADIA Quarter 1, FY19 earnings call is on Nov 05, 2018, 4 PM EST.
Expect an update on Trofinetide (potentially even on Fragile X steering committee outcomes) by then.
2. A professional friend contacted the company recently and was informed some of key management are overseas. Here's hoping in N.A. ahead of updates ahead of the ACADIA earnings call and/or with institutions as part of the overseas road-show (announced on 06/09/2018).
3. On relative valuations, look at BIT.ax. At 21c their diluted market cap of 150m is approx. 50% higher than NEU's for a much poorer proposition in my opinion - at least this highlights some more money flowing into Australian biotech at least.
Regards,
5x8's
Ann: Neuren and Lanstead agree to pause settlements for 120 days, page-68
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
$14.20 |
Change
0.890(6.69%) |
Mkt cap ! $1.761B | |||
| Open | High | Low | Value | Volume |
| $13.50 | $14.26 | $12.96 | $9.111M | 655.8K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 2000 | $14.17 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $14.23 | 3278 | 1 |
View Market Depth
| Last trade - 16.15pm 27/06/2025 (20 minute delay) ? |
| NEU (ASX) Chart |